| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.2 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.27 | 0.2 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.2 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.2 |